Silvant Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-414,654
Closed -$38.3M 306
2024
Q2
$38.3M Buy
414,654
+42,157
+11% +$3.73M 1.7% 13
2024
Q1
$35.6M Buy
372,497
+66,744
+22% +$5.61M 1.7% 15
2023
Q4
$23.3M Sell
305,753
-1,907
-0.6% -$133K 1.25% 19
2023
Q3
$21.3M Sell
307,660
-674
-0.2% -$54.2K 1.29% 19
2023
Q2
$29.1M Buy
308,334
+534
+0.2% +$46.4K 1.64% 14
2023
Q1
$25.5M Sell
307,800
-19,141
-6% -$1.5M 1.66% 13
2022
Q4
$24.4M Sell
326,941
-8,842
-3% -$681K 1.73% 12
2022
Q3
$27.7M Buy
335,783
+300,973
+865% +$29M 1.89% 12
2022
Q2
$3.31M Buy
34,810
+53
+0.2% +$5.49K 0.8% 27
2022
Q1
$4.09M Sell
34,757
-424
-1% -$47.6K 0.78% 28
2021
Q4
$4.56M Sell
35,181
-1,567
-4% -$183K 0.78% 28
2021
Q3
$4.16M Sell
36,748
-6,910
-16% -$789K 0.74% 30
2021
Q2
$4.52M Sell
43,658
-733
-2% -$69.1K 0.71% 31
2021
Q1
$3.71M Sell
44,391
-1,309
-3% -$111K 0.63% 37
2020
Q4
$4.17M Sell
45,700
-9,696
-18% -$804K 0.71% 30
2020
Q3
$4.42M Sell
55,396
-14,421
-21% -$1.13M 0.83% 24
2020
Q2
$4.83M Sell
69,817
-4,511
-6% -$321K 0.87% 24
2020
Q1
$4.67M Sell
74,328
-1,425
-2% -$103K 1.02% 19
2019
Q4
$5.89M Sell
75,753
-1,065
-1% -$83.2K 1.07% 19
2019
Q3
$5.63M Sell
76,818
-9,606
-11% -$675K 1.11% 19
2019
Q2
$5.32M Sell
86,424
-8,067
-9% -$488K 0.95% 26
2019
Q1
$6.03M Sell
94,491
-30,531
-24% -$1.74M 1.08% 25
2018
Q4
$6.38M Sell
125,022
-3,468
-3% -$175K 1.28% 13
2018
Q3
$7.46M Sell
128,490
-20,196
-14% -$988K 0.92% 29
2018
Q2
$7.21M Sell
148,686
-1,692
-1% -$79K 0.89% 29
2018
Q1
$6.99M Buy
+150,378
New +$6.53M 0.9% 28

Other funds holding EW